Details for Patent: 10,888,544
✉ Email this page to a colleague
Which drugs does patent 10,888,544 protect, and when does it expire?
Patent 10,888,544 protects CERDELGA and is included in one NDA.
This patent has fifteen patent family members in thirteen countries.
Summary for Patent: 10,888,544
Title: | Methods for treating Gaucher disease |
Abstract: | Methods for treating Gaucher disease in patients with renal or hepatic impairment. |
Inventor(s): | Li; Jing (Bridgewater, NJ), Peterschmitt; M. Judith (Watertown, MA), Kanamaluru; Vanaja (Bridgewater, NJ), Chen; Jun (Bridgewater, NJ), Gaemers; Sebastiaan J. M. (Naarden, NL), Rudin; Dan (Cambridge, MA) |
Assignee: | GENZYME CORPORATION (Cambridge, MA) |
Application Number: | 16/219,064 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,888,544
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genzyme Corp | CERDELGA | eliglustat tartrate | CAPSULE;ORAL | 205494-001 | Aug 19, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | LONG-TERM TREATMENT OF ADULTS WITH GAUCHER DISEASE TYPE 1 WHO ARE CYP2D6 EXTENSIVE METABOLIZERS WITH MODERATE TO SEVERE RENAL IMPAIRMENT | ⤷ Sign Up | |||
Genzyme Corp | CERDELGA | eliglustat tartrate | CAPSULE;ORAL | 205494-001 | Aug 19, 2014 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | LONG-TERM TREATMENT OF ADULTS WITH GAUCHER DISEASE TYPE 1 WHO ARE CYP2D6 EXTENSIVE METABOLIZERS WITH MILD HEPATIC IMPAIRMENT AND ARE CONCURRENTLY TAKING A STRONG OR MODERATE CYP3A INHIBITOR | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,888,544
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018386182 | ⤷ Sign Up | |||
Brazil | 112020011056 | ⤷ Sign Up | |||
Canada | 3083663 | ⤷ Sign Up | |||
China | 111479591 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |